Professor Matthew Wilson is the NIHR CRN National Speciality Lead for Anaesthesia, Perioperative Medicine and Pain Management.
Professor Wilson trained in medicine at Oxford University Medical School and, after experience in acute medicine, completed specialist training in anaesthesia in the Midlands. As a Lecturer, he acquired formal training in clinical trials and applied health research with Birmingham University Department of Public Health & Epidemiology.
After working for as an NHS consultant in tertiary centres in the UK and US, he was awarded a NIHR "Clinician Scientist" Fellowship in 2011.
Since 2014, Professor Wilson has been a clinical academic at the School of Health and Related Research (ScHARR) Sheffield University. He is an expert in the fields of applied health research, quantative clinical trials and health technology evaluation in perioperative medicine, reproductive health and acute pain.
He has a grant portfolio exceeding £10M and has led 3 NIHR multicenter randomized trials (BUMPES, SALVO and RESPITE), recruiting over 6700 participants.
Professor Wilson’s current research interests are directed toward the prediction and prevention of new onset Atrial Fibrillation after cancer resection surgery (AFAR), the epigenetics of epidural related maternal fever (EPIFEVER) and the prevention and treatment of post-operative delirium.
Matt supervises and mentors NIHR Academic Clinical Fellows, Clinical Lecturers and Intermediate Fellows. He is director of ScHARR MB ChB Public Health teaching for student doctors in Sheffield. Since, 2017, he’s served as Grants Officer to the National Institute of Academic Anaesthesia.
Matt holds an honorary consultant post with Sheffield Teaching Hospitals NHS Trust and practises at the Royal Hallamshire Hospital.